HIV diagnoses in France declined between 2013 and 2018, corresponding with introduction of universal ART provision in 2013 and large-scale PrEP rollout in 2016.
Updated analysis of 2016 continuum of HIV care found that 11 mostly Western European countries are on track to meet UNAIDS 90-90-90 goal
Community viremia and HIV incidence both significantly decreased from 2012-2017 among gay and bisexual men in Australia.
Low prevalence of transmitted ARV resistance and clinically relevant resistance to recommended first-line ARVs observed in cohort of ART-naive PWH in Spain.
Analysis of the EuResist database reveals prevalence and predictors of resistance to all 4 main ARV drug classes in treatment-experienced patients in Europe.
Reduced inpatient and outpatient visits observed following SVR with oral HCV DAA therapy in real-world HIV/HCV-coinfected population.
HCV incidence in MSM with HIV in France declined from 2014 to 2017 following unrestricted access of HCV DAA therapy for persons with HIV.